Jana Selent

Dr. Jana Selent

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2014 in Bioinformatics
Verified
Journal Article
Open access
PDF file
RGRamon Guixà-González
Ramon Guixà-González
IEIsmael Rodríguez Espigares
Ismael Rodríguez Espigares
JRJuan Manuel Ramírez-Anguita
Juan Manuel Ramírez-Anguita
PCPau Carrió-Gaspar
Pau Carrió-Gaspar
HMHector Martinez-Seara
Hector Martinez-Seara
JSJana Selent
Jana Selent
Summary: Computer simulations are giving way to more complex and accurate studies of biological membranes by molecular dynamics (MD) simulations. The analysis of MD trajectories comprises the biophysical characterization of membrane properties or the study of protein–lipid interactions and dynamics. However, there is a lack of automated tools to analyse MD simulations of complex membrane or membrane-protein systems. Here we present MEMBPLUGIN, a plugin for the Visual Molecular Dynamics package that provides algorithms to measure a host of essential biophysical properties in simulated membranes. MEMBPLUGIN features are accessible both through a user-friendly graphical interface and as command-line procedures to be invoked in analysis scripts. Availability and implementation: MEMBPLUGIN is a VMD extension written in Tcl. Multi-platform source code, documentation and tutorials are freely available at http://membplugin.sourceforge.net. Contact:toni.giorgino@isib.cnr.it or jana.selent@upf.edu Supplementary information: Supplementary data are available at Bioinformatics online.

27 March 2022 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
PKPeter Kolb
Peter Kolb
TKTerry Kenakin
Terry Kenakin
SASteve Alexander
Steve Alexander
MBMarcel Bermudez
Marcel Bermudez
LBLaura M. Bohn
Laura M. Bohn
DGDavid E. Gloriam
David E. Gloriam
G protein-coupled receptors modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved drugs. Depending on which ligand activates a receptor, it can engage different intracellular transducers. This ‘biased signaling’ paradigm requires that we now characterize physiological signaling not just by receptors but by ligand-receptor pairs. Ligands eliciting biased signaling may constitute better drugs with higher efficacy and fewer adverse effects. However, ligand bias is very complex, making reproducibility and description challenging. Here, we provide guidelines and terminology for any scientists to design and report ligand bias experiments. The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities continue to advance our understanding and exploitation of ligand bias. Scientific insight, biosensors, and analytical methods are still evolving and should benefit from and contribute to the implementation of the guidelines, together improving translation from in vitro to disease-relevant in vivo models.

11 June 2015 in The Journal of Membrane Biology
Verified
Journal Article
Closed access
PDF file
ZCZoe Cournia
Zoe Cournia
TAToby W. Allen
Toby W. Allen
IAIoan Andricioaei
Ioan Andricioaei
BABruno Antonny
Bruno Antonny
DBDaniel Baum
Daniel Baum
ABAna-Nicoleta Bondar
Ana-Nicoleta Bondar

13 July 2020 in Nature Methods
Verified
Journal Article
Closed access
PDF file
IEIsmael Rodríguez Espigares
Ismael Rodríguez Espigares
MTMariona Torrens-Fontanals
Mariona Torrens-Fontanals
JTJohanna K. S. Tiemann
Johanna K. S. Tiemann
DADavid Aranda-García
David Aranda-García
JRJuan Manuel Ramírez-Anguita
Juan Manuel Ramírez-Anguita
JSJana Selent
Jana Selent

21 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
RGRamon Guixà-González
Ramon Guixà-González
JAJosé L. Albasanz
José L. Albasanz
IEIsmael Rodríguez Espigares
Ismael Rodríguez Espigares
MPManuel Pastor
Manuel Pastor
FSFerran Sanz
Ferran Sanz
JSJana Selent
Jana Selent
Cholesterol is a key component of cell membranes with a proven modulatory role on the function and ligand-binding properties of G-protein-coupled receptors (GPCRs). Crystal structures of prototypical GPCRs such as the adenosine A2A receptor (A2AR) have confirmed that cholesterol finds stable binding sites at the receptor surface suggesting an allosteric role of this lipid. Here we combine experimental and computational approaches to show that cholesterol can spontaneously enter the A2AR-binding pocket from the membrane milieu using the same portal gate previously suggested for opsin ligands. We confirm the presence of cholesterol inside the receptor by chemical modification of the A2AR interior in a biotinylation assay. Overall, we show that cholesterol’s impact on A2AR-binding affinity goes beyond pure allosteric modulation and unveils a new interaction mode between cholesterol and the A2AR that could potentially apply to other GPCRs.

22 January 2016 in Scientific Reports
Verified
Journal Article
Open access
RGRamon Guixà-González
Ramon Guixà-González
MJMatti Javanainen
Matti Javanainen
MGMaricel Gomez-Soler
Maricel Gomez-Soler
BCBegoña Cordobilla
Begoña Cordobilla
JDJoan Domingo
Joan Domingo
JSJana Selent
Jana Selent
Membrane levels of docosahexaenoic acid (DHA), an essential omega-3 polyunsaturated fatty acid (ω-3 PUFA), are decreased in common neuropsychiatric disorders. DHA modulates key cell membrane properties like fluidity, thereby affecting the behaviour of transmembrane proteins like G protein-coupled receptors (GPCRs). These receptors, which have special relevance for major neuropsychiatric disorders have recently been shown to form dimers or higher order oligomers and evidence suggests that DHA levels affect GPCR function by modulating oligomerisation. In this study, we assessed the effect of membrane DHA content on the formation of a class of protein complexes with particular relevance for brain disease: adenosine A2A and dopamine D2 receptor oligomers. Using extensive multiscale computer modelling, we find a marked propensity of DHA for interaction with both A2A and D2 receptors, which leads to an increased rate of receptor oligomerisation. Bioluminescence resonance energy transfer (BRET) experiments performed on living cells suggest that this DHA effect on the oligomerisation of A2A and D2 receptors is purely kinetic. This work reveals for the first time that membrane ω-3 PUFAs play a key role in GPCR oligomerisation kinetics, which may have important implications for neuropsychiatric conditions like schizophrenia or Parkinson’s disease.